Second National Consultation on the Use of Antiretroviral Pre-exposure Prophylaxis (‎PrEP)‎ to Prevent HIV Acquisition, 4 June 2018, Kuala Lumpur, Malaysia : meeting report

Overview

Oral pre-exposure prophylaxis of HIV infection (PrEP) is defined as the use of antiretroviral drugs by people who do not have HIV infection to prevent the acquisition of HIV. The World Health Organization (WHO) recommends that people at high risk of HIV acquisition should be offered PrEP.